MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
170 hedge funds and large institutions have $2.33B invested in Momenta Pharmaceuticals, Inc. in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 69 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+16
Holders Change %
+10.39%
% of All Funds
3.36%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
35
Increased
69
Reduced
40
Closed
14
Calls
$5.31M
Puts
$1.15M
Net Calls
+$4.16M
Net Calls Change
+$3.8M
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$63.9M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$54.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$50.3M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$35.3M |
| 5 |
BlackRock
New York
|
+$29.6M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$19M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.7M |
| 3 |
Renaissance Technologies
New York
|
-$10.5M |
| 4 |
Millennium Management
New York
|
-$5.55M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$5.52M |
